Defining the metabolomic profile associated with early cardiotoxicity in patients with breast cancer treated with anthracyclines

被引：0
|
作者：
Cocco, D. [1 ]
Ferro, E. G. [2 ]
Ricci, S. [1 ]
Deidda, M. [1 ]
Noto, A. [1 ]
Madeddu, C. [1 ]
Atzori, F. [1 ]
Scarlozzi, M. [1 ]
Mercuro, G. [1 ]
Dessalvi, C. Cadeddu [1 ]
机构：
[1] Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3289 / 3289
页数：1
相关论文
共 50 条
  • [41] Echocardiographic and biological prospective assessment of cardiotoxicity in patients with breast cancer receiving taxanes, anthracyclines and/or trastuzumab
    Peset Cubero, A. M.
    Cortell Fuster, A.
    Rodriguez Navarro, C.
    Solloso Martinez, A.
    Facila Rubio, L.
    Montagud Balaguer, V.
    Soler Lopez, J.
    Olmos Anton, S.
    Munarriz Ferrandis, J.
    Martinez De Duenas, E.
    EUROPEAN HEART JOURNAL, 2013, 34 : 211 - 212
  • [42] The prospects for applications of cardiometric approach in evaluation of cardiotoxicity under Anthracyclines therapy in patients with breast cancer
    Shikhlyarova, Alla, I
    Vladimirova, Lyubov Y.
    Tikhanovskaya, Natalia M.
    Arapova, Yulia Y.
    Protasova, Tatiana P.
    Sycheva, Elena A.
    Ryadinskaya, Lyudmila A.
    Lyanoval, Aza A.
    Popova, Irina L.
    Abramova, Natalia A.
    Novoselova, Kristina A.
    Storozhakova, Anna E.
    Ezhova, Maria O.
    Shatova, Yuliana S.
    Lisutin, Aleksandr E.
    Pozdnyakova, Viktoria V.
    Dashkova, Irina R.
    Babieva, Stella M.
    CARDIOMETRY, 2018, (13): : 15 - 21
  • [43] SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab
    Meattini, Icro
    Curigliano, Giuseppe
    Terziani, Francesca
    Becherini, Carlotta
    Airoldi, Mario
    Allegrini, Giacomo
    Amoroso, Domenico
    Barni, Sandro
    Bengala, Carmelo
    Guarneri, Valentina
    Marchetti, Paolo
    Martella, Francesca
    Piovano, Pierluigi
    Vannini, Agnese
    Desideri, Isacco
    Tarquini, Roberto
    Galanti, Giorgio
    Barletta, Giuseppe
    Livi, Lorenzo
    MEDICAL ONCOLOGY, 2017, 34 (05)
  • [44] SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab
    Icro Meattini
    Giuseppe Curigliano
    Francesca Terziani
    Carlotta Becherini
    Mario Airoldi
    Giacomo Allegrini
    Domenico Amoroso
    Sandro Barni
    Carmelo Bengala
    Valentina Guarneri
    Paolo Marchetti
    Francesca Martella
    Pierluigi Piovano
    Agnese Vannini
    Isacco Desideri
    Roberto Tarquini
    Giorgio Galanti
    Giuseppe Barletta
    Lorenzo Livi
    Medical Oncology, 2017, 34
  • [45] CARDIOTOXICITY IN PATIENTS OF EWINGS SARCOMA TREATED WITH A COMBINATION OF ANTHRACYCLINES AND ALKYLATING AGENTS
    Sharma, R.
    Pradhan, N.
    Dwivedi, P.
    Prasad, M.
    Chinnaswamy, G.
    Arora, B.
    Kurkure, P.
    Banavali, S.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 90 - 90
  • [46] Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines
    Thavendiranathan, Paaladinesh
    Houbois, Christian
    Marwick, Thomas H.
    Kei, Tiffanie
    Saha, Sudipta
    Runeckles, Kyle
    Huang, Flora
    Shalmon, Tamar
    Thorpe, Kevin E.
    Pezo, Rossanna C.
    Prica, Anca
    Maze, Dawn
    Abdel-Qadir, Husam
    Connelly, Kim A.
    Chan, Joyce
    Billia, Filio
    Power, Coleen
    Hanneman, Kate
    Wintersperger, Bernd J.
    Brezden-Masley, Christine
    Amir, Eitan
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (06) : 515 - 525
  • [47] Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis
    Mary Obasi
    Arielle Abovich
    Jacqueline B. Vo
    Yawen Gao
    Stefania I. Papatheodorou
    Anju Nohria
    Aarti Asnani
    Ann H. Partridge
    Cancer Causes & Control, 2021, 32 : 1395 - 1405
  • [48] Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis
    Obasi, Mary
    Abovich, Arielle
    Vo, Jacqueline B.
    Gao, Yawen
    Papatheodorou, Stefania I.
    Nohria, Anju
    Asnani, Aarti
    Partridge, Ann H.
    CANCER CAUSES & CONTROL, 2021, 32 (12) : 1395 - 1405
  • [49] Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study
    Cortes-Salgado, Alfonso
    Jose Serrano, Juan
    Cordero Pereda, David
    Menacho, Miriam
    Manuel Del Rey, Jose
    del Campo-Albendea, Laura
    Saavedra, Cristina
    Chamorro, Jesus
    Rosero, Diana
    Sotoca, Pilar
    Guillen-Ponce, Carmen
    Guerra, Eva
    Fernandez-Abad, Maria
    Lopez-Miranda, Elena
    Martinez-Janez, Noelia
    Gion, Maria
    Teresa Salazar, Maria
    Agudo-Quilez, Pilar
    Garrido, Pilar
    Alonso Salinas, Gonzalo Luis
    ONCOLOGIST, 2024,
  • [50] Characterization of hiPSC-CMs derived from pediatric cancer patients treated with anthracyclines that suffered cardiotoxicity
    Reinal, I.
    Ontoria-Oviedo, I.
    Casini, M.
    Tejedor, S.
    Sanchez-Sanchez, R.
    Buigues, M.
    Amaro-Prellezo, E.
    Ciria, M.
    Peiro-Molina, E.
    Raya, A.
    Sepulveda, P.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A145 - A146
12345